Preliminary Trends of the EORTC Study Comparing Postoperative Chemotherapy, Immunotherapy, Chemoimmunotherapy or Abstention in Squamous Cell Bronchial Carcinoma

  • L. Israel
  • A. Depierre
  • R. Sylvester
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 68)


This is a very short interim report since, due to the stratification according to nodal status and the first random allocation to groups with and without radiotherapy, there are 16 subgroups among 310 patients available for analysis. For this reason, the EORTC expects no conclusive results before 2 additional years of follow-up. Nevertheless, some trends are beginning to appear that will be summarized below and should be considered as very preliminary.


Minimal Residual Disease Random Allocation Conclusive Result Minimal Residual Medical Treatment Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Israel, L.: Nonspecific immunostimulation in bronchogenic cancer. Scand. J. Resp. Dis. [Suppl.] 89, 95–105 (1974).Google Scholar
  2. 2.
    Israel, L., Edelstein, R., Depierre, A., Dimitrov, N.: Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: A preliminary report of clinical and biologic findings. J.N.C.I. 55, 29–33 (1975).Google Scholar
  3. 3.
    Israel, L.: Nonspecific immune stimulation with corynebacteria in lung cancer. In: Lung cancer. Natural history, prognosis, and therapy. Israël, L., Chahinian, P. (eds.), Vol. I, pp. 273-280. New York-London: Academic Press 1976.Google Scholar
  4. 4.
    Israel, L., Edelstein, R.: In vivo and in vitro studies on nonspecific blocking factors of host origin in cancer patients. Role of plasma exchange as an immunotherapeutic modality. Isr. J. Med. Sci. 14, 105–130 (1978).PubMedGoogle Scholar
  5. 5.
    Israel, L.: An immunological look at the TNM classification therapeutic implications and strategies. Cancer Treat. Rep. (1978) (in press).Google Scholar
  6. 6.
    McKneally, M. F., Maver, C., Kansel, H. W.: Regional immunotherapy of lung cancer with intrapleural BCG. Lancet 1976/I, 377-379.Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1979

Authors and Affiliations

  • L. Israel
  • A. Depierre
  • R. Sylvester

There are no affiliations available

Personalised recommendations